History of cardiovascular events and cardiovascular risk factors among patients initiating strontium ranelate for treatment of osteoporosis

PURPOSE: To estimate the proportion of osteoporosis patients in whom initiating strontium ranelate treatment, under new EMA guidelines, should be contraindicated because of a history of cardiovascular events or risk for cardiovascular events. MATERIALS AND METHODS: This was a retrospective analysis...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Jingbo, Tang, Jackson, Li, Zhiyi, Sajjan, Shiva, O’Regan, Christopher, Modi, Ankita, Sazonov, Vasilisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4655964/
https://www.ncbi.nlm.nih.gov/pubmed/26604831
http://dx.doi.org/10.2147/IJWH.S88627

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4655964/
https://www.ncbi.nlm.nih.gov/pubmed/26604831
http://dx.doi.org/10.2147/IJWH.S88627

Ejemplares similares